In collaboration with Cochrane France; commissioned by WHO Health Emergencies Programme (WHE);

Cochrane Response is part of the operating team of the COVID-19 living systematic review and network meta-analysis initiatiative. COVID-NMA is an international initiative working in conjunction with the World Health Organization (WHO), led by a team of researchers from Cochrane and other institutions (Université de Paris, Inserm, CNRS, Centre for Evidence-Based Medicine Odense (CEBMO), University of Southern Denmark, Odense University Hospital, Epistemonkos Foundation, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Milan).

Rapid reviews on treatments for COVID-19: Hydroxychloroquine

Rapid reviews on treatments for COVID-19: Lopinavir/ritonavir

In collaboration with Cochrane France; commissioned by WHO Health Emergencies Programme (WHE); We deliviered evidence summaries for these rapid reviews to the comissioner

Changing physical environments to change behaviours to reduce transmission of SARS-CoV-2

Commissioned by the UK Innovation and Research, Economic and Social Research Council; Scoping review and rapid review: Encouraging behaviour change to reduce COVID-19 transmission: A summary of two rapid evidence reviews

COVID-19 DTA rapid reviews

Contributing towards updates of the following Cochrane rapid reviews:
1. Antibody tests for identification of current and past infection with SARS-CoV-2
2. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID‐19 disease